KLA Corp. vs 22nd Century Group Inc — how do they compare? KLA Corp. trades at $195.57 (market cap $256.72B), while 22nd Century Group Inc trades at $0.81 (market cap $621.67K). The key difference: KLA Corp. is far larger — about 412952.2× 22nd Century Group Inc's market cap, and KLA Corp. pays a 0.47% dividend while 22nd Century Group Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold KLA Corp. for 60 Days and 22nd Century Group Inc for 32 Days on average.
| KLAC | XXII | |
|---|---|---|
Market Cap | $256.72B | $621.67K |
Volume | 9,970,753 | 45,625 |
Sector | Technology | Consumer Staples |
52-Week High | $301.71 | $483.00 |
52-Week Low | $98.28 | $0.80 |
Typical Hold Time | 60 Days | 32 Days |
Enterprise Value | $257.97B | -$3.69M |
Dividend Yield | 0.47% | — |
Signals from Pluang's Aura AI — not financial advice
KLA Corporation (KLAC) trades at $196.72, showing slight daily weakness but maintaining a strong uptrend supported by bullish technical indicators and robust fundamentals. The company reported revenue of $12.16 billion in 2025 with a net income margin of 35.57%, and has consistently beaten earnings expectations in recent quarters. AI-driven demand is fueling growth, with a backlog of $12.57 billion highlighting strong future revenue visibility.
The outlook for KLAC remains positive, driven by semiconductor equipment demand from AI and advanced packaging. Key opportunities include market leadership in inspection and metrology, while risks involve competitive pressures from Applied Materials and ASML, and execution challenges in scaling operations. The consensus price target of $223.88 suggests significant upside potential from current levels.
XXII trades at $0.8116, down 8.96% in the last session, with a bearish technical signal from moving averages. The company shows negative profitability metrics including -76.01% net income margin and -284.5% ROE, though valuation ratios appear low with P/S of 0.08 and P/B of 0.03. Recent news highlights regulatory progress in reduced-nicotine tobacco initiatives in France and Europe.
While analyst consensus is 75% buy with a $1,240 price target suggesting significant upside, fundamental challenges persist with consecutive earnings misses and negative cash flow from operations. The stock faces execution risk in commercializing its reduced-nicotine platform amid ongoing losses.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
KLA designs and manufactures yield-management and process-monitoring diagnostic and control systems for the semiconductor manufacturing industry. The systems are used to analyze the manufacturing process at various steps in a semiconductor's development. The firm's laser-scanning products are used for wafer qualification, process monitoring, and equipment monitoring. KLA also provides inspection tools and systems for optical metrology and e-beam metrology.
Read more on KLAC →22nd Century Group is a plant biotechnology company that uses genetic engineering and gene editing to control the levels of nicotine in tobacco plants. Its flagship product line, VLN®, is the first and only combustible cigarette authorized by the FDA as a Modified Risk Tobacco Product (MRTP), containing 95% less nicotine than traditional cigarettes to help adult smokers smoke less.
Read more on XXII →